chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shoulder pain; Arm still hurts; Can't throw a ball or move my arm quickly; with limited range of motion at times; This is a spontaneous report from a contactable consumer (patient). A 53-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via intramuscular route of administration in the right arm/shoulder on 25Feb2021 at 15:00 (Batch/Lot Number: EN6202, at age 53-years-old at vaccination) as a single dose for COVID-19 immunisation at a civic center (non-military facility). Medical history included diabetes mellitus from 2017 and ongoing, hypertension from 2017 and ongoing. There was no known allergies. The patient did not have COVID-19 prior to vaccination. The concomitant medication taken within two weeks of the BNT162B2 vaccine were unspecified. There was no other vaccine taken within four weeks of vaccination. On 25Feb2021 at 15:00, the patient received the first dose of the BNT162B2 vaccine. On 26Feb2021 at 07:00, the patient experienced shoulder pain, arm hurting and cant throw a ball or move my arm quickly. Clinical course: The first vaccine shot was given high up on the right shoulder. The pain started within 24hrs and never went away. It hurts off and on with limited range of motion at times. The pain stops her from doing normal things. She can't throw a ball or move her arm quickly. On 18Mar2021 at 15:00, she received the second shot in the left arm, which was sore the next few days and then went back to normal, but the right arm where she received the first shot still aches. The right arm still aches like this for about 5 months. It was hurting less now but still certain movements cause pain and she still cannot move her arm to throw anything. It does however feel better than a month ago (4 months after the first shot). The patient didn't seek medical attention because of the cost and was just hoping it would heal. The arm still hurts. She cannot throw without a popping sound inside the muscle. Certain movements are very painful and she has to be careful how she moves it. Seriousness criteria was reported as persistent, significant disability and incapacity. No treatment was received. The patient did not test for COVID-19 post vaccination. The outcome of events shoulder pain, arm hurting and can't throw a ball or move arm quickly, limited range of motion at times  was not recovered.   Follow-up attempts are completed: no further information is expected.
She experienced headache, dizziness and SOB. Later she developed diarrhea, then swelling in her both feet and right knee. She was admitted to the hospital for tests last Friday night and was discharged with gout. They drew fluid from her knee and left ankle. She is in a wheelchair at home.
pt states on 3/15/2021 he started getting fatigue and chills.  He woke up on 3/16/2021 with itching and bumps under the skin on his buttocks that have spread to his stomach, thighs and forearms.  Pt states the fatigue and chills are better today.  His temp is 97.8.  Pt has taken Benadryl for his symptom's. Pt will call and schedule to see his PCP today.
She had the vaccine on 5/16 around 10:00am. The symptoms started at 5:00pm on 5/16 exp extreme sharp chest pains with difficulty breathing. We did give her Tylenol for pain for sharp pain around 7 pm started to come back. She was taken to ER to make sure it was not related to the vaccine. At the ER she had Chest X-rays, EKG, Bloodwork and her D-Dimer test was elevated she had a CT scan done showed  swollen lymph nodes on (left arm)no problems with her heart.We was told to follow up with pcp told to continue to watch her for myocarditis. She has a follow up Sonogram scheduled on 7/16 to ensure the swelling of the lymph nodes has went down.
Raised, red right upper arm, itchy and shoulder to elbow moves area well. Unable to reach parent (phone unlisted), number above is wrong.
Baby could not lift head or extremities; fever 101.2; legs shook in evening; next day still would not walk or crawl; recommend ER visit.
2 weeks after taking the vaccine and had developed a Peritonitis which is fungal in nature; This is a spontaneous report from a contactable consumer who reported for his father that an 85-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration on 25Feb2021 as single dose for covid-19 immunisation. Medical history included peritoneal dialysis. The patient's concomitant medications were not reported.  Patient's son asking in behalf of his father seeking information if these is any reported data on patient undergoing peritoneal dialysis experiencing peritonitis (fungal in nature) as a side effect after taking the PFIZER BIONTECH COVID19 vaccine. Also, he was asking if there were any reported serious adverse events as well with other patients with co-morbidities after taking the Pfizer Biontech Covid19 Vaccine. Patient had the first dose of the vaccine 25Feb2021, he is a peritoneal dialysis patient and has been hospitalized since 10Mar2021, 2 weeks after taking the vaccine and had developed a Peritonitis which is fungal in nature (Mar2021). He also mentioned that he and his family has been sanitary and careful in caring for their father given the underlying condition. He also mentioned that 25% of the people he knew with underlying condition such as heart disease, Hashimoto's, Raynaud syndrome and Chron's disease had experience side effects after taking the vaccine. Outcome of the event was unknown.   Information about lot/batch has been requested.
8 days from date of vaccine site on arm became very red, swollen, itching, sore and continues until today with swelling and soreness, used Benadryl otc for itching , ibuprofen for pain and swelling
2nd dose give 49 days after 1st injection; This spontaneous case was reported by a health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose give 49 days after 1st injection) in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029L20A and 036A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose give 49 days after 1st injection). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose give 49 days after 1st injection) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: Non significant follow up received on 11-JUN-2021, no new information
Moderna Lot 025L20A Four to Five days after this patient received the Moderan vaccine on 1/7/2021 a half dollar size red rash appeared at the injection site on arm. Patient did not take any medication for the itching. Pharmacist and on site vaccine clinic provider decided to give the patient 10mg of Zyrtec x1 dose prior to second Moderan vaccine shot, and have patient wait 30 minutes after vaccine was administered on 2/1/2021. Patient had not have any reaction during the 30 minute observation.
It started off with a severe headache, chills, body aches, cough, sinuses are stuffy, and very sore throat it felt like I was swallowing glass. I tested positive for COVID-19 at home. I talked to my doctor and they prescribed me Paxlovid and Benzonatate. I still have a bad cough and body pains.
Hives started on arms within a week of vaccination; hives itch; hives rash/spread to my leg/knee area; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 46-year-old male patient received BNT162b2 (BNT162B2), on 30Mar2022 at 18:45 as dose 3 (booster), single (Lot number: FJ9943) at the age of 46 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "known allergies: Not that I'm aware of besides weeds" (unspecified if ongoing). Concomitant medication(s) included: ALLERGY MEDICINE. Past drug history included: Poison ivy, reaction(s): "known allergies". Vaccination history included: BNT162b2 (Dose 2, Product: COVID 19, Brand: COVID 12 yrs (Purple CAP Pfizer), Lot number: FF2588, Dose administration time: 07:45 PM, Vaccine location: Left arm), administration date: 20Sep2021, when the patient was 46-year-old, for COVID-19 immunization; BNT162b2 (Dose 1, Product: COVID 19, Brand: COVID 12 yrs (Purple CAP Pfizer), Lot number: FC3182, Dose administration time: 07:45 PM, Vaccine location: Left arm), administration date: 30Aug2021, when the patient was 46-year-old, for COVID-19 immunization. The following information was reported: URTICARIA (non-serious) with onset 06Apr2022, outcome "not recovered", described as "Hives started on arms within a week of vaccination"; PRURITUS (non-serious) with onset 06Apr2022, outcome "not recovered", described as "hives itch"; RASH (non-serious) with onset 06Apr2022, outcome "not recovered", described as "hives rash/spread to my leg/knee area". The events "hives started on arms within a week of vaccination", "hives itch" and "hives rash/spread to my leg/knee area" required physician office visit. Therapeutic measures were taken as a result of urticaria, pruritus, rash.  Additional information: The patient had not other vaccine in four weeks. Patient had received other medications in two weeks with allergy medicine. Reporter stated, hives started on arms within a week of vaccination. The hives itch as well. Still have hives rash almost 6 weeks after vaccine shot, had for about 5 of those 6 weeks. It has now spread to my leg/knee area. Sought medical attention on 25Apr2022 for relief, was prescribed prednisone tablets and relieved itching, but still have hives. Sought additional medical attention from allergist on 05May2022 for further relief and prescribed Fluocinonide Ointment to put on rash. It relieves itching, but still have hives and appearing in other areas on body. Does not seem to be going away anytime soon. The patient was visited to doctor or other healthcare professional office/clinic visit for adverse event. Prednisone tablets and fluocinonide ointment as treatment was received for the events. The patient had not covid prior vaccination and had not covid tested post vaccination. Other medical history was none.  No follow-up attempts are possible. No further information is expected.
flu like symptoms during the night (same day of vaccination); This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 59 year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), administration date 23Mar2021 10:00 (Batch/Lot number: unknown) at the age of 59 years as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162B2 (DOSE 1, SINGLE), for COVID-19 immunisation. The following information was reported: INFLUENZA LIKE ILLNESS (non-serious) with onset 23Mar2021, outcome "unknown", described as "flu like symptoms during the night (same day of vaccination)".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Received vaccine 1230 on 7/31/07. Pt. reports woke 0630 on 8/1/07 with swollen lips, lightly red face and bilateral swollen hands. Resolved in 2 hours with Benadryl. NO recurrence. Pt also started new multivitamin on 7/30/07. D/C'ed after.
Patient experienced swelling of his arm, an arm rash and bruise-like discoloration of whole arm, not just the injection site; bruise-like discoloration of whole arm; Patient experienced swelling of his arm, an arm rash and bruise-like discoloration of whole arm, not just the injection site; Patient experienced swelling of his arm, an arm rash and bruise-like discoloration of whole arm, not just the injection site; This spontaneous report has been received from a pharmacist referring a 79-year-old male patient. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not reported.  On 17-NOV-2022, the patient was vaccinated with the first dose of pneumococcal vaccine (+) polyvalent (23-valent) (PNEUMOVAX23) injection, at a dose of 0,5 milliliter, lot number W021636 with expiration date 01-OCT-2023, administered intramuscularly for prophylaxis (strength, vaccination scheme and anatomical site of application were not provided).   On an unknown date in November in 2022, the patient experienced swelling of his arm (arm unspecified by health care professional) (peripheral swelling), an arm rash (rash) and bruise-like discoloration of whole arm (contusion, skin discolouration), not just the injection site. At time of reporting, the patient was recovering from the events.   The causal relationship between the events and pneumococcal vaccine (+) polyvalent (23-valent) (PNEUMOVAX23) was not reported.   This is one of two reports received from the same reporter. ; Sender's Comments:  US-009507513-2211USA007016:
Patient presented to Outpatient Clinic 10/27/17 with significant arm swelling and erythema. Patient received the influenza vaccine on 9/29/17 per documentation. Patient was treated with a cold compress and instructed to follow up with clinic.
Patient experienced a brain hemorrhage and was hospitalized on Monday, March 15. Despite numerous tests, doctors could not find the source or cause of the bleeding. Over time, the bleeding spread to other areas of her brain including her brain stem. Damage from the bleeding was so severe that she would not recover. She passed away on March 24 after being removed from life support.
Two days after my flu shot I broke out in a severe rash on my legs. It is raised red bumps that itch severely. I also broke out with pustules (pencil eraser to dime-sized) on my back and stomach. Other than the flu shot there were no changes to my diet or medication during this time, so I drew the conclusion that it must be an adverse reaction to the vaccination.
Patient c/o weakness and feeling dizzy, EMT notified at 12:20, EMT assessed patient, VSS 157/93 HR 97 RR 26 O2 98% BGM 129 at 1430. At 1440 146/95 HR 93 RR 18 O2 95%.  EMT did not administer any medications, EKG Normal sinus. Fire department recommended patient to hospital as she was alone and driving herself. Fire department escorted patient to hospital via ambulance as a precaution at 1456.
Fever, Swelling, itchiness, and infection around injection site. treated with antibiotics
Joint Aches, Nausea, Constipation lasting until 10/22/2010 6:00 a.m.
had Shingles and also had the vaccine / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient had Shingles and also had the vaccine when it came out. This case was considered as suspected vaccination failure, as details regarding completion of primary vaccination schedule, laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Information has been received from a nurse practitioner concerning herself, a 60 year old female with no pertinent medical history and no known drug reactions/allergies who on approximately 21-MAR-2007 was vaccinated with Zostavax. There was no concomitant medication. On approximately 23-MAR-2007, two days after she received one dose of the Zostavax, the patient experienced redness and itching at the injection site area. The patient sought unspecified medical attention. The symptoms lasted three days. On approximately 25-MAR-2007, the patient recovered from redness and itching at the injection site area.  Additional information has been requested. Follow-up information received from the physician office indicating that the nurse practitioner was vaccinated SC with a first dose of ZOSTAVAX on 05-APR-2007 at 17:15. The patient developed mild erythema and site pruritis. The events cleared up in 48 hours. No additional information is expected.
High pitch uncontrollable crying for > 4 hrs next day seems lethargic.
1010: After receiving the Covid vaccine, the pt began c/o CP x 3 min; initially moderate "4-5" 1013: BP 132/70 HR 65 RR 16 SpO2 100% 1014: CP decreased to "3-4" 1017: CP "1-2" 1022: CP "0-1" 1025: Pt now feels "normal" 1035:  Pt offered UC but declined; pt encouraged to f/u w/PCP; rec'd ER precautions; pt released home
8 days p/vax broke out in gen rash & T102, fuzzy;no other sx;on the next day had hives all over body;temp was up & down x 2 days;never above 102;pt was not seen by MD;advised DPH & APAP per phone;devel no other sx & hives disappeared x 3day
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching around injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE RASH (Rash around injection site) and RASH (Rash fades away and comes back) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015m20a) for COVID-19 vaccination. Concurrent medical conditions included Hypertension. Concomitant products included TOCOPHERYL ACETATE (EVITA) for an unknown indication. On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Feb-2021, the patient experienced VACCINATION SITE PAIN (Pain at the injection site). On 15-Feb-2021, the patient experienced VACCINATION SITE PRURITUS (Itching around injection site) and VACCINATION SITE RASH (Rash around injection site). On an unknown date, the patient experienced RASH (Rash fades away and comes back). At the time of the report, VACCINATION SITE PRURITUS (Itching around injection site), VACCINATION SITE PAIN (Pain at the injection site), VACCINATION SITE RASH (Rash around injection site) and RASH (Rash fades away and comes back) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown. Concomitant medication included Blood pressure medications. Treatment information was not provided.
Swelling, Erythema right deltoid 7.5 x 10.5 cm.
L deltoid became red, swollen and tender 2 days post immunizations. IPV and DTaP given 8/19/03. Fever of 99.1 F x 2d. MMR given in RA SQ on 8/19/03 area also itched. Area is slightly swollen and red today 8/22/03, but symptoms are resolving.
A female consumer reported that she was given influenza virus vaccine, trivalent, types A & B 2001-2002 formula. Subsequent to immunization, her arm became swollen. No further information was available at the date of this report. This report was received from manufacturer.
102 Fever, whole body sourness, headache, fatigue, weakness, lasted 2 1/2 days.
no adverse event; the patient was inadvertently administered a expired dose of ROTATEQ; This spontaneous report was received from a medical assistant and refers to a patient of unknown age and gender.     The patient's concurrent conditions, medical history and concomitant medications were not reported.  On 11-MAY-2020, the medical assistant reported that the patient was inadvertently administered an expired dose of rotavirus vaccine, live, oral, pentavalent (ROTATEQ)(lot # R027159 with expiration date of 30-APR-2020, oral, frequency not reported) for prophylaxis. There was no temperature excursion. No additional adverse event (AE) information was reported.
Mild redness, itching and soreness at injection site ~9 days after injection; Mild redness, itching and soreness at injection site ~9 days after injection; Mild redness, itching and soreness at injection site ~9 days after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL3247) via an unspecified route of administration in the left arm on 02Mar2021 at 09:00(at the age of 34-years-old) as a single dose for COVID-19 immunisation. The medical history included penicillin allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The concomitant medications were not reported. On 11Mar2021, approximately 9 days after the injection, the patient experienced mild redness, itching and soreness at injection site. The adverse events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events mild redness, itching and soreness at injection site was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
very sick; This spontaneous case was reported by a patient family member or friend and describes the occurrence of VACCINATION COMPLICATION (very sick) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.     On 31-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 31-Jan-2021, the patient experienced VACCINATION COMPLICATION (very sick). On 02-Feb-2021, VACCINATION COMPLICATION (very sick) had resolved.            No concomitant medications were provided. No treatment information provided.
Patient experienced redness/irritation on arm of injection site for 7 days following immunization. Did not appear to be an allergic reaction as no hives, itching, or involvement of throat/lips/face. Localized reaction encompassed injection site on arm as well as surrounding area of upper arm.
This spontaneous report was received from a registered nurse, concerning unspecified number of patients of unknown age and gender. There were no concurrent conditions, medical history, drug reactions or allergies or concomitant medications reported. On unspecified dates, the patients were vaccinated with improperly stored doses of PNEUMOVAX 23 injection vials (dose, frequency and route were not reported) lot # M043424 with expiration date of 06-JUN-2018, for prophylaxis. The temperature of the PNEUMOVAX 23 was between 0 °C and 1 °C (1 °C) for a time frame of 30 minutes; below -1 °C (-1°C) for a time frame of 30 minutes.. No previous temperature excursion occurred and no data logger was involved. No adverse effects were reported. This is one of three reports received from the same source. Additional information has been requested. Sender's Comments: US-009507513-1705USA000411: US-009507513-1705USA000410.
Moderate right wrist joint ache , Severe lower back and right hip ache ,  Very tired and moderately sickness of my stomach. In 1992 I had a herniated disk in lower lumbar region , adverse effect felt exactly the same, My wife had to help me into and out of bed. One I took medication, I slept.  Very painful. Have mostly recovered from effects, still slightly sore in lower back.
Pt. arm started with swollen, red, welt the size of a quarter. Overnight it grew 4 times in size, red and hard and tender. Pt. treated with BENADRYL and Prednisolone.